A feasible Study on the measurement of blood levels of anti-cancer drugs
Not Applicable
Recruiting
- Conditions
- cancer
- Registration Number
- JPRN-UMIN000049429
- Lead Sponsor
- ational cancer center hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who are determined to be ineligible for this study by the principal investigator or the study office (2) Patients with active blood-borne infection (HIV, HBV, HCV, etc.) when measured by the DPS method
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess whether measurement data by the pharmacist can be achieved within 90 minutes of specimen submission at each patient's first measurement of blood levels of antineoplastic drugs.
- Secondary Outcome Measures
Name Time Method